Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection

Neuroscience

Volumn 144, Issue 3, 2007, Pages 1141-1151

  O'Dell, S J ^a   Gross, N B ^a   Fricks, A N ^a   Casiano, B D ^a   Nguyen, T B ^a   Marshall, J F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

6 hydroxydopamine; basal ganglia; DAT; movement disorders; Parkinson's; tyrosine hydroxylase

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG INDUCED DISEASE; FORELIMB; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; NERVE ENDING; NERVE INJURY; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BINDING; RAT; STEREOTAXIC SURGERY; SUBSTANTIA NIGRA; TREADMILL EXERCISE;

ANIMALS; BINDING, COMPETITIVE; CELL SURVIVAL; COCAINE; CORPUS STRIATUM; CYTOPROTECTION; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EXERCISE THERAPY; MALE; NERVE DEGENERATION; NEURAL PATHWAYS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SUBSTANTIA NIGRA; TREATMENT OUTCOME; TYROSINE 3-MONOOXYGENASE; UP-REGULATION; VOLITION;

EID: 33845796526     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.10.042     Document Type: Article

References (51)

1. Abercrombie E.D., Bonatz A.E., and Zigmond M.J. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525 1 (1990) 36-44
2. Agid Y., Cervera P., Hirsch E., Javoy-Agid F., Lehericy S., Raisman R., and Ruberg M. Biochemistry of Parkinson's disease 28 years later: a critical review. Mov Disord 4 Suppl 1 (1989) S126-S144
3. Altar C.A., O'Neil S., and Marshall J.F. Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats. Neuropharmacology 23 3 (1984) 309-318
4. Baatile J., Langbein W.E., Weaver F., Maloney C., and Jost M.B. Effect of exercise on perceived quality of life of individuals with Parkinson's disease. J Rehabil Res Dev 37 5 (2000) 529-534
5. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., and Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20 4 (1973) 415-455
6. Bezard E., Gross C.E., and Brotchie J.M. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci 26 4 (2003) 215-221
7. Bjorklund A., and Lindvall O. Self-repair in the brain. Nature 405 6789 (2000) 892-893 895
8. Boja J.W., Mitchell W.M., Patel A., Kopajtic T.A., Carroll F.I., Lewin A.H., Abraham P., and Kuhar M.J. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12 1 (1992) 27-36
9. Bové J., Prou D., Perier C., and Przedborski S. Toxin-induced models of Parkinson's disease. NeuroRx 2 3 (2005) 484-494
10. Cohen A.D., Tillerson J.L., Smith A.D., Schallert T., and Zigmond M.J. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem 85 2 (2003) 299-305
11. Cotman C.W., and Berchtold N.C. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25 6 (2002) 295-301
12. Cotman C.W., and Engesser-Cesar C. Exercise enhances and protects brain function. Exerc Sport Sci Rev 30 2 (2002) 75-79
13. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 6 (2003) 889-909
14. de Goede C.J., Keus S.H., Kwakkel G., and Wagenaar R.C. The effects of physical therapy in Parkinson's disease: a research synthesis. Arch Phys Med Rehabil 82 4 (2001) 509-515
15. Finkelstein D.I., Stanic D., Parish C.L., Tomas D., Dickson K., and Horne M.K. Axonal sprouting following lesions of the rat substantia nigra. Neuroscience 97 (2000) 99-112
16. Fisher B.E., Petzinger G.M., Nixon K., Hogg E., Bremmer S., Meshul C.K., and Jakowec M.W. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 77 3 (2004) 378-390
17. Gomez-Pinilla F., Dao L., and So V. Physical exercise induces FGF-2 and its mRNA in the hippocampus. Brain Res 764 1-2 (1997) 1-8
18. Hornykiewicz O., and Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45 (1987) 19-34
19. Howells F.M., Russell V.A., Mabandla M.V., and Kellaway L.A. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease. Behav Brain Res 165 2 (2005) 210-220
20. Kirik D., Rosenblad C., and Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152 2 (1998) 259-277
21. Kozlowski M.R., and Marshall J.F. Recovery of function and basal ganglia [14C]2-deoxyglucose uptake after nigrostriatal injury. Brain Res 259 2 (1983) 237-248
22. Mabandla M., Kellaway L., St. Clair G.A., and Russell V.A. Voluntary running provides neuroprotection in rats after 6-hydroxydopamine injection into the medial forebrain bundle. Metab Brain Dis 19 (2004) 43-50
23. Marshall J.F. Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: spontaneous recovery and pharmacological control. Brain Res 177 2 (1979) 311-324
24. Marshall J.F., Richardson J.S., and Teitelbaum P. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J Comp Physiol Psychol 87 5 (1974) 808-830
25. Marshall J.F., Turner B.H., and Teitelbaum P. Sensory neglect produced by lateral hypothalamic damage. Science 174 8 (1971) 523-525
26. Miyai I., Fujimoto Y., Ueda Y., Yamamoto H., Nozaki S., Saito T., and Kang J. Treadmill training with body weight support: its effect on Parkinson's disease. Arch Phys Med Rehabil 81 7 (2000) 849-852
27. Moroz I.A., Pecina S., Schallert T., and Stewart J. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine. Exp Neurol 189 1 (2004) 78-93
28. Neeper S.A., Gomez-Pinilla F., Choi J., and Cotman C. Exercise and brain neurotrophins. Nature 373 6510 (1995) 109
29. Nieuwboer A., De Weerdt W., Dom R., Truyen M., Janssens L., and Kamsma Y. The effect of a home physiotherapy program for persons with Parkinson's disease. J Rehabil Med 33 6 (2001) 266-272
30. Ouchi Y., Kanno T., Okada H., Yoshikawa E., Futatsubashi M., Nobezawa S., Torizuka T., and Tanaka K. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease. Brain 124 (2001) 784-792
31. Palmer S.S., Mortimer J.A., Webster D.D., Bistevins R., and Dickinson G.L. Exercise therapy for Parkinson's disease. Arch Phys Med Rehabil 67 10 (1986) 741-745
32. Paxinos G., and Watson G. The rat brain in stereotaxic coordinates. 5th edition (2005), Elsevier, New York
33. Poulton N.P., and Muir G.D. Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-parkinsonian rats. Exp Neurol 193 1 (2005) 181-197
34. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., and Togasaki D.M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67 3 (1995) 631-647
35. Reuter I., Engelhardt M., Stecker K., and Baas H. Therapeutic value of exercise training in Parkinson's disease. Med Sci Sports Exerc 31 11 (1999) 1544-1549
36. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 5 (2000) 777-787
37. Schallert T., and Woodlee M.T. Brain-dependent movements and cerebral-spinal connections: key targets of cellular and behavioral enrichment in CNS injury models. J Rehabil Res Dev 40 4 Suppl 1 (2003) 9-17
38. Schwarting R.K., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50 2-3 (1996) 275-331
39. Smith A.D., and Zigmond M.J. Can the brain be protected through exercise?. Lessons from an animal model of parkinsonism. Exp Neurol 184 1 (2003) 31-39
40. Snyder G.L., Keller Jr. R.W., and Zigmond M.J. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J Pharmacol Exp Ther 253 2 (1990) 867-876
41. Stanic D., Tripanichkul W., Drago J., Finkelstein D.I., and Horne M.K. Glial responses associated with dopaminergic striatal reinnervation following lesions of the rat substantia nigra. Brain Res 1023 (2004) 83-91
42. Sunvisson H., Lokk J., Ericson K., Winblad B., and Ekman S.L. Changes in motor performance in persons with Parkinson's disease after exercise in a mountain area. J Neurosci Nurs 29 4 (1997) 255-260
43. Tillerson J.L., Caudle W.M., Reveron M.E., and Miller G.W. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease. Neuroscience 119 3 (2003) 899-911
44. Tillerson J.L., Cohen A.D., Caudle W.M., Zigmond M.J., Schallert T., and Miller G.W. Forced nonuse in unilateral parkinsonian rats exacerbates injury. J Neurosci 22 15 (2002) 6790-6799
45. Tillerson J.L., Cohen A.D., Philhower J., Miller G.W., Zigmond M.J., and Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 21 12 (2001) 4427-4435
46. Tripanichkul W., Stanic D., Drago J., Finkelstein D.I., and Horne M.K. D2 dopamine receptor blockade results in sprouting of DA axons in the intact animal but prevents sprouting following nigral lesions. Eur J Neurosci 17 (2003) 1033-1045
47. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol Scand Suppl 367 (1971) 49-68
48. Ungerstedt U. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367 (1971) 95-122
49. Zigmond M.J., Berger T.W., Grace A.A., and Stricker E.M. Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism. Mol Chem Neuropathol 10 3 (1989) 185-200
50. Zigmond M.J., Hastings T.G., and Abercrombie E.D. Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease. Ann N Y Acad Sci 648 (1992) 71-86
51. Zigmond M.J., and Stricker E.M. Parkinson's disease: studies with an animal model. Life Sci 35 1 (1984) 5-18